Abstract
Wolman disease is characterized by severe diarrhea and malnutrition leading to death during infancy. Lysosomal acid lipase deficiency is the cause of the symptoms and signs. It is inherited in an autosomal recessive manner. All Wolman disease patients have adrenal gland calcification. Previous therapeutic attempts have failed to provide remission. We report successful long-term bone marrow engraftment in a patient with Wolman disease resulting in continued normalization of peripheral leukocyte lysosomal acid lipase enzyme activity. Diarrhea is no longer present. Now, at 4 years of age, this patient is gaining developmental milestones. Cholesterol and triglyceride levels are normal. Liver function is normal. This is the first long-term continued remission reported for Wolman disease. Bone Marrow Transplantation (2000) 26, 567–570.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abramov A, Schorr S, Wolman M . Generalized xanthomatosis with calcified adrenals J Dis Child 1956 91: 282–286
Wolman M, Sterk VV, Gatt S, Frenkel M . Primary familial xanthomatosis with involvement and calcification of the adrenals: report of two more cases in siblings of a previously described infant Pediatr 1961 28: 742–757
Kyriakides EC, Paul B, Balint JA . Lipid accumulation and acid lipase deficiency in fibroblasts from a family with Wolman's disease and their apparent correction in vitro J Lab Clin Med 1972 80: 810–816
Assmann G, Seedorf U . Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease McGraw-Hill: New York 1995 2563–2587
Jyonouchi H, Cyong J-Ç, Shen F-W et al. Alteration of murine serum lipase activity after allogeneic bone marrow transplantation Clin Immunol Immunopathol 1982 22: 94–104
Krivit W, Freese D, Chan KW, Kulkarni R . Wolman's disease: review of treatment with bone marrow transplantation and considerations for the future Bone Marrow Transplant 1992 10: (Suppl. 1) 97–101
Jones S, Rogers TR, Henry K et al. Wolman's disease treated by displacement bone marrow transplantation. In: Hobbs JR (ed) Correction of Certain Genetic Diseases by Transplantation COGENT: London 1989 43–47
Dusenbery KE, Gerbi BJ . Total body irradiation in conditioning regimens for bone marrow transplantation. In Levitt SH, Potish RA, Khan FM, Perez CM (eds) Levitt and Tapley's Technological Basis of Radiation Therapy: Clinical Applications Williams and Wilkins: Baltimore 1999 pp499–518
Wagner JE, Santos GW, Noga SJ et al. Bone marrow graft engineering by counterflow centrifugal elutriation. Results of a phase I–III clinical trial Blood 1990 75: 1370–1374
Blazar B, Orr HT, Arthur DC et al. Restriction fragment length polymorphism (RFLP) as markers of engraftment in allogeneic bone marrow transplantation Blood 1985 66: 1436–1439
Anderson RA, Sando GN . Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases J Biol Chem 1991 266: 22479–22484
Muretto P, Del Fiasco S, Angelucci E et al. Bone marrow transplantation in thalassemia: modifications of hepatic iron overload and associated lesions after long-term engrafting Liver 1994 14: 14–24
Locasciulli A, Testa M, Valsecchi MG et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study Blood 1997 90: 3799–3805
Lucarelli G, Clift RA, Galimberti M et al. Marrow transplantation for patients with thalassemia: results in class 3 patients Blood 1996 87: 2082–2088
Hsu Y-S, Hwu W-L, Huang S-F et al. Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation Bone Marrow Transplant 1999 24: 103–107
Pagani F, Pariyarath R, Garcia R et al. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease J Lipid Res 1998 39: 1382–1398
Redonnet-Vernhet I, Chatelut M, Basile J-P et al. Cholesteryl ester storage disease: relationship between molecular defects and in situ activity of lysosomal acid lipase Biochem Mol Med 1997 62: 42–49
Du H, Duanmu M, Witte D, Grabowski GA . Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage Hum Mol Genet 1998 7: 1347–1354
Du H, Sheriff S, Bezerra, J et al. Molecular and enzymatic analysis of lysosomal acid lipase in cholesteryl ester storage disease Mol Genet Metab 1998 64: 126–134
Ries S, Buchler G, Schindler G et al. Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals Hum Mut 1998 12: 44–51
Anderson RA, Bryson GM, Parks JS . Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease Mol Genet Metab 1999 68: 333–345
Acknowledgements
This work was supported in part by NIH NS-29099 Study of Value of Bone Marrow Transplantation for Storage Diseases (WK) and Children's Cancer Research Fund, University of Minnesota (WK, CP).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krivit, W., Peters, C., Dusenbery, K. et al. Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant 26, 567–570 (2000). https://doi.org/10.1038/sj.bmt.1702557
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702557
Keywords
This article is cited by
-
Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working Party
Bone Marrow Transplantation (2023)
-
Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up
Orphanet Journal of Rare Diseases (2021)
-
Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency
Orphanet Journal of Rare Diseases (2020)
-
Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study
Orphanet Journal of Rare Diseases (2017)
-
Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics
Orphanet Journal of Rare Diseases (2017)